Jury Awards Blinded Woman $21M Over Sulindac

Law360, New York (September 9, 2010, 12:12 PM EDT) -- A federal jury has awarded $21 million to a woman who was blinded and suffered a near-fatal skin disease after taking anti-inflammatory drug Sulindac, dealing a blow to generic-drug company Mutual Pharmaceutical Co.

Plaistow, N.H., resident Karen Bartlett is entitled to $4.5 million in lost earning ability and ongoing medical expenses and another roughly $16.5 million to compensate for loss of enjoyment of life, a jury found Wednesday in the U.S. District Court for the District of New Hampshire.

An attorney for 51-year-old Bartlett confirmed the...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.